Tag Archives: Evista
Latest Medical Consensus on Preventing Breast Cancer
Breast cancer is the most common cancer in women worldwide, with the annual incidence estimated to be 1.4 million cases in 2008. Rates are highest in North American, Western Europe andAustralia, but the rates are also increasing in developing countries. … Continue reading
Posted in Breast cancer, Cancer
Tagged anastrozole, Arimidex, Aromasin, arzoxifene, Bisphosphonates, Breast cancer, Cancer prevention, COX-2 inhiitors, Evista, exemestane, Fablyn, Femara, lasofoxifene, letrozole, Metformin, Nolvadex, NSAIDs, raloxifene, retinoids, rexinoids, selective estrogen-receptor modulators, SERMS, tamoxifen
Comments Off on Latest Medical Consensus on Preventing Breast Cancer